Articles by Disease (Pancreas Cancer)

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4
Page: 174-179
Author(s): Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker

Apoptotic Signaling in Pancreatic Cancer – Therapeutic Application (Supplemental Data)

Journal: Current Cancer Therapy Reviews
Volume: 5
Page: 122-133
Author(s): Felix Ruckert, Christian Pilarsky, Hans-Detlev Saeger and Robert Grutzmann

Recent Advances and Developments in Treatment Strategies Against Pancreatic Cancer

Journal: Current Clinical Pharmacology
Volume: 4
Page: 102-112
Author(s): Rosemary A. Fryer, Christine Galustian and Angus G. Dalgelish

Transport of Nucleoside Analogs Across the Plasma Membrane: A Clue to Understanding Drug-Induced Cytotoxicity

Journal: Current Drug Metabolism
Volume: 10
Page: 347-358
Author(s): I. Huber-Ruano and M. Pastor-Anglada

Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy

Journal: Current Drug Discovery Technologies
Volume: 6
Page: 72-81
Author(s): Kurt Van der Speeten, Oswald Anthony Stuart and Paul H. Sugarbaker

Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9
Page: 162-184
Author(s): Jose J.G. Marin, Marta R. Romero, Alba G. Blazquez, Elisa Herraez, Emma Keck and Oscar Briz

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

Journal: Current Medicinal Chemistry
Volume: 15
Page: 3052-3061
Author(s): Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Hiroko Nakajima, Zheyu Li, Ichiro Kawase, Yusuke Oji and Haruo Sugiyama